MA28276A1 - Preparation effervescente d'une substance basique a action pharmaceutique - Google Patents

Preparation effervescente d'une substance basique a action pharmaceutique

Info

Publication number
MA28276A1
MA28276A1 MA29140A MA29140A MA28276A1 MA 28276 A1 MA28276 A1 MA 28276A1 MA 29140 A MA29140 A MA 29140A MA 29140 A MA29140 A MA 29140A MA 28276 A1 MA28276 A1 MA 28276A1
Authority
MA
Morocco
Prior art keywords
basic substance
pharmaceutical action
effervescent preparation
effervescent
preparation
Prior art date
Application number
MA29140A
Other languages
English (en)
Inventor
Wolfgang Wiehl
Irene Loose
Ralf Buellesbach
Dieter Rehn
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of MA28276A1 publication Critical patent/MA28276A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

Préparation effervescente d'une substance basique à action pharmaceutique La présente invention se rapporte à une préparation effervescente comprenant une composition effervescente, au moins une substance basique à action pharmaceutique et, le cas échéant, un ou plusieurs autres ingrédients actifs, qui se caractérise par le fait que l'alcalisation de l'urine et, par conséquent, l'accumulation accrue de la substance basique à action pharmaceutique sont évitées, aux médicaments contenant cette préparation effervescente, aux procédés de production de ces médicaments et à leur utilisation.
MA29140A 2003-12-19 2006-06-26 Preparation effervescente d'une substance basique a action pharmaceutique MA28276A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10359790A DE10359790A1 (de) 2003-12-19 2003-12-19 Brausezubereitung einer basischen arzneilich wirksamen Substanz

Publications (1)

Publication Number Publication Date
MA28276A1 true MA28276A1 (fr) 2006-11-01

Family

ID=34683574

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29140A MA28276A1 (fr) 2003-12-19 2006-06-26 Preparation effervescente d'une substance basique a action pharmaceutique

Country Status (16)

Country Link
EP (1) EP1696874A1 (fr)
JP (1) JP2007515418A (fr)
KR (1) KR20060109492A (fr)
CN (1) CN1893920A (fr)
AR (1) AR046955A1 (fr)
AU (1) AU2004308590A1 (fr)
BR (1) BRPI0417796A (fr)
CA (1) CA2550342A1 (fr)
DE (1) DE10359790A1 (fr)
EC (1) ECSP066649A (fr)
IL (1) IL176356A0 (fr)
MA (1) MA28276A1 (fr)
MX (1) MXPA06006658A (fr)
NO (1) NO20063327L (fr)
WO (1) WO2005063199A1 (fr)
ZA (1) ZA200604946B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9078824B2 (en) 2007-09-24 2015-07-14 The Procter & Gamble Company Composition and method of stabilized sensitive ingredient
TR201107202T1 (tr) * 2008-11-11 2012-02-21 Berko �La� Ve K�Mya Sanay� A.�. İbuprofen, psödoefedrin ve klorfeniramin içeren bir farmasötik bileşim.
KR101057640B1 (ko) * 2009-05-27 2011-08-18 (주)다산메디켐 발포성 층을 포함하는 다층 정제
WO2013109224A1 (fr) * 2012-01-18 2013-07-25 Mahmut Bilgic Compositions pharmaceutiques contenant du diclofénac
CN104622831B (zh) * 2013-11-06 2018-06-22 江苏豪森药业集团有限公司 一种口服片剂及其制备方法
CN107951034B (zh) * 2017-12-01 2021-03-23 郑州拓洋生物工程有限公司 维生素泡腾制剂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4613497A (en) * 1984-02-29 1986-09-23 Health Products Development, Inc. Dry, water-foamable pharmaceutical compositions
CA2021548A1 (fr) * 1989-09-01 1991-03-02 Ronald Nash Duvall Compose medicinal effervescent a teneur reduite en sodium pour le soulagement des symptomes du rhume et des allergies
CA2084028A1 (fr) * 1991-11-27 1993-05-28 Harish B. Pandya Composition pour le traitement de la grippe
AU7407194A (en) * 1993-08-03 1995-02-28 Warner-Lambert Company Pleasant tasting effervescent cold/allergy medications
JP2000063269A (ja) * 1998-08-20 2000-02-29 Taiho Yakuhin Kogyo Kk 固形製剤

Also Published As

Publication number Publication date
CA2550342A1 (fr) 2005-07-14
CN1893920A (zh) 2007-01-10
WO2005063199A1 (fr) 2005-07-14
BRPI0417796A (pt) 2007-03-20
JP2007515418A (ja) 2007-06-14
AU2004308590A1 (en) 2005-07-14
EP1696874A1 (fr) 2006-09-06
DE10359790A1 (de) 2005-07-21
KR20060109492A (ko) 2006-10-20
IL176356A0 (en) 2006-10-05
ECSP066649A (es) 2006-10-25
AR046955A1 (es) 2006-01-04
NO20063327L (no) 2006-07-18
MXPA06006658A (es) 2006-08-31
ZA200604946B (en) 2007-09-26

Similar Documents

Publication Publication Date Title
MY138289A (en) Pharmaceutical compositions
MA29378B1 (fr) Composition pharmaceutique comprenant une diphenyluree substituee par un omega-carboxyaryle pour le traitement du cancer
NO20042596L (no) Inbibitorer av 11-beta-hydroksy steroid dehydrogenase type 1
MA27347A1 (fr) Inhibiteurs de protease du vih, compositions les contenant, leurs utilisations pharmaceutiques et matieres pour leur synthese
MXPA04004842A (es) Inhibidores de 11-(-hidroxiesteroide deshidrogenasa de tipo 1.
MXPA04004837A (es) Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1.
SE0001899D0 (sv) New compounds
TNSN98017A1 (fr) Derives de sulfonyluree, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN07476A1 (fr) Derives de n-(pyridine -2- yl) - sulfonamide
MA27443A1 (fr) Oxazoles et thiazoles nouveaux servant d'inhibiteurs du facteur de croissance transformant (tgf)
MA29693B1 (fr) Derives de xanthine en tant qu'agonistes hm74a selectifs
MA34655B1 (fr) Dérivés de 2,3- dihydroimidazo[1,2-c]quinazoléine substitués par un aminoalcool utiles pour traiter des troubles hyperprolifératifs et des maladies associées à l'angiogenèse
MA27937A1 (fr) Dérivés d'indazole 3, 5-disubstitués, compositions pharmaceutiques, et méthodes de médiation ou d'inhibition de la prolifération cellulaire
MA30041B1 (fr) Immunoglobulines
MA27729A1 (fr) Compositions pharmaceutiques solides contenant un agoniste des recepteurs de la s1p et un alcool de sucre
TN2009000059A1 (fr) Formes de dosage pharmaceutiques orales anti-manipulation contenant un analgesique opioide
TNSN01145A1 (fr) Derives d'imidazole a noyau aryle ou heteroaryle condense, et compositions les contenant.
MA27093A1 (fr) Derives de sulfonamides, leur preparation et leur application comme medicaments.
MA30539B1 (fr) Derives de piperazinyle utiles dans le traitement de maladies induites par le recepteur gpr38.
MA28038A1 (fr) Thienopyrazoles
MA29723B1 (fr) Composes
DE69836678D1 (de) Chinolin- und chinazolinderivate als antagonisten des corticotropin freisetzenden faktors (crf)
TNSN01052A1 (fr) Metabolites du (-) - cis - 6 - phenyl - 5 - [4 -( 2-pyrrolidine -1- yl - ethoxy) - phenyl] - 5,6,7,8- tetrahydro - naphtalene - 2 - ol et compositions les contenant
TNSN00139A1 (fr) Acides phenoxyacetiques substitues
ATE241348T1 (de) Nimesulide-haltige topische arzneimittel